CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

Andere talen Chongqing Zhifei Biological Products Co., Ltd.

Aandelen

300122

CNE100000V20

Farmaceutische producten

Slotkoers Shenzhen S.E. Andere beurzen 09-01-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
19,80 ^CNY	+1,69%		+4,93%	+4,93%

04:55	CA111-injectie van Zhifei Biological Products dochteronderneming start fase I klinische proeven; Aandelen stijgen met 3%	MT
12/11	Chongqing Zhifei Biological Products-dochteronderneming krijgt goedkeuring in China voor klinische proeven met gordelroos- en waterpokkenvaccin	MT

Andere talen

04:55	Zhifei Biological Products Unit's CA111 injection Enters Phase I Clinical Trials; Shares Up 3%
12/11	Chongqing Zhifei Biological Products Subsidiary Gets China Nod for Shingles, Chickenpox Vaccine
29-10-25	Zhifei biological products' Q3 net loss at 601.1 million yuan
29-10-25	Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
19-08-25	Chongqing Zhifei Biological Products Swings to Loss in H1 as Revenue Plunges 73%
18-08-25	Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
18-08-25	Zhifei biological products h1 net loss at 597.1 million yuan
06-06-25	Zhifei Biological Products' Pneumonia Vaccine Enters Production Registration Review
03-06-25	Chinese Drug Regulator Accepts Chongqing Zhifei Biological Products' Application to Produce Meningococcal Vaccine
22-04-25	Zhifei Biological Products Falls to Q1 Loss as Revenue Falls 79%
22-04-25	Zhifei Biological Products' 2024 Profit Down 75%; Shares Fall 7%
21-04-25	Zhifei Biological Products Says 2024 Net Profit Down 75.0% Y/Y
21-04-25	Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
21-04-25	Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
21-03-25	Zhifei Biological To Boost Investment In Biopharma Firm
21-03-25	Chongqing Chenan Biopharmaceutical Co., Ltd. announced that it expects to receive CNY 593.265306 million in funding from Chongqing Zhifei Biological Products Co., Ltd.
18-12-24	Chongqing Zhifei Biological Products Co., Ltd. Announces Third Quarter 2024 Profit Distribution Plan (A Shares), Payable on 25 December 2024
09-12-24	Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement
05-12-24	GSK, China's Zhifei Extend Shingles Shot Collaboration to 2034
05-12-24	GSK expands deal with China's Zhifei to explore RSV vaccine collaboration
05-12-24	GSK plc and Zhifei Biological Products, Ltd Revise and Extend Strategic Vaccine Collaboration in China
28-10-24	Chongqing Zhifei Biological Products Co., Ltd. Announces Profit Distribution Proposal for the Third Quarter of 2024
25-10-24	Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
23-09-24	Chongqing Zhifei Biological Products Co., Ltd. Approves Election of Zhang Xinrong as Independent Director
29-08-24	Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen MarketScreener-artikels MarketScreener-analyses Ideeën voor de handel

Andere talen Chongqing Zhifei Biological Products Co., Ltd.

Aandelen

300122

CNE100000V20

Farmaceutische producten

Andere talen

Filters